At a glance
- Originator Nihon Schering
- Class Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 17 Jun 2004 Discontinued - Preclinical for Cognition disorders in Japan (unspecified route)
- 25 Aug 1998 No-Development-Reported for Cognition disorders in Japan (Unknown route)
- 22 Apr 1996 New profile